3-(Arylcycloiminoalkyl)benzisothiazole 1,1-dioxides

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

26029357, 2602948C, 260301, 424263, 424267, 544368, A61K 31495, C07D41712

Patent

active

041043871

ABSTRACT:
3-(Arylcycloiminoalkyl)benzisothiazole 1,1-dioxides are provided having the structure ##STR1## wherein R is hydrogen, halogen, lower alkyl, lower alkoxy or nitro; R.sup.1 is hydrogen, lower alkoxy or halogen with the proviso that R.sup.1 can be lower alkoxy or halogen only when R is lower alkoxy or halogen, respectively; A is O or NH; X is hydrogen, halogen lower alkyl, lower alkoxy, or trifluoromethyl; Y is C or N, where Y is C, is a double bond, and when Y is N, represents a single bond, B is an alkylene group containing 2 to 5 carbons in the normal chain; Q is a single bond or an alkylene group containing 1 to 3 carbons in the normal chain; and physiologically acceptable acid-addition salts thereof. These compounds are useful as antiinflammatory agents.

REFERENCES:
patent: 2751392 (1956-06-01), Grogan et al.
patent: 3787411 (1974-01-01), Ruschig et al.
patent: 4000274 (1976-12-01), Renth et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3-(Arylcycloiminoalkyl)benzisothiazole 1,1-dioxides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-(Arylcycloiminoalkyl)benzisothiazole 1,1-dioxides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(Arylcycloiminoalkyl)benzisothiazole 1,1-dioxides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1979906

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.